Flow cytometry detection of minimal residual disease in multiple myeloma: Lessons learned at FDA-NCI roundtable symposium

Am J Hematol. 2014 Dec;89(12):1159-60. doi: 10.1002/ajh.23831.
No abstract available

Publication types

  • Letter

MeSH terms

  • Biomarkers, Tumor / analysis*
  • Biomarkers, Tumor / genetics
  • Congresses as Topic
  • Flow Cytometry / statistics & numerical data*
  • Humans
  • Multiple Myeloma / diagnosis*
  • Multiple Myeloma / genetics
  • Multiple Myeloma / mortality
  • Multiple Myeloma / pathology
  • Neoplasm, Residual / diagnosis*
  • Neoplasm, Residual / genetics
  • Neoplasm, Residual / mortality
  • Neoplasm, Residual / pathology
  • Survival Analysis

Substances

  • Biomarkers, Tumor